<DOC>
	<DOCNO>NCT00349674</DOCNO>
	<brief_summary>Remission ANCA-associated vasculitis obtain approximately 80 % patient combination corticosteroid cyclophosphamide . However , relapse frequent . This point warrant prescription maintenance treatment less toxic immunosuppressant several month year . The optimal drug indication determine . We decide therefore compare 2 use drug indication . Induction therapy consist combination corticosteroid intravenous cyclophosphamide pulse . Corticotherapy consist first one daily methylprednisolone pulse , 1 3 day , follow oral prednisolone dose 1 mg/kg/d 3 week , progressively taper stop 18th month diagnosis . Cyclophosphamide administer every 2 week first 3 bolus ( 0.6 g/m2 - D1 , 15 30 ) , every 3 week ( 0.7 g/m2 ) . Once remission achieve , patient receive 3 additional bolus ( 0.7 g/m2 ) . At time , patient randomize maintenance treatment azathioprine ( 2 mg/kg/d , orally ) oral methotrexate ( start dose 0.3 mg/kg/wk , progressively increase every week 2.5mg , necessary , maximum optimal dose 25 mg/wk ) 12 month .</brief_summary>
	<brief_title>WEGENT - Comparison Methotrexate Azathioprine Maintenance Therapy ANCA-Associated Vasculitides</brief_title>
	<detailed_description />
	<mesh_term>Vasculitis</mesh_term>
	<mesh_term>Granulomatosis Polyangiitis</mesh_term>
	<mesh_term>Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis</mesh_term>
	<mesh_term>Methotrexate</mesh_term>
	<mesh_term>Azathioprine</mesh_term>
	<criteria>Patients age 18 yearsold newly diagnose systemic Wegener 's granulomatosis , microscopic polyangitis least one factor poor prognosis accord five factor score ( proteinuria &gt; 1 g/day , renal insufficiency define serum creatininemia &gt; 140 Âµmol/L , specific cardiomyopathy , gastrointestinal tract and/or CNS involvement ) . MPA patient poor prognosis factor ; localize WG ; relapse previously know WG MPA ; treatment corticosteroid 1 month prior diagnosis start immunosuppressant ; coexistence another multisystem autoimmune disease ; malignancy ( unless consider complete remission therapy least 3 year ) ; contraindication corticosteroid study immunosuppressant ; pregnancy use contraception nonmenopaused woman ; infection human immunodeficiency virus ; mental physical disturbance permit give consent .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Wegener 's granulomatosis ,</keyword>
	<keyword>microscopic polyangiitis ,</keyword>
	<keyword>ANCA-associated vasculitis ,</keyword>
	<keyword>methotrexate ,</keyword>
	<keyword>azathioprine</keyword>
</DOC>